Onconova Therapeutics Inc...

NASDAQ: ONTX · Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Apr 02, 2024, 10:00 PM

Onconova Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-166,523B -18.95M -18.96M -16.16M
Depreciation & Amortization
12B 16K 14K 14K
Stock-Based Compensation
1,390B 1.3M 1.17M 576K
Other Working Capital
n/a -226K 382K -1.52M
Other Non-Cash Items
n/a 1,770B 98K -321K
Deferred Income Tax
n/a -1,770B -98K n/a
Change in Working Capital
n/a -301K 1.48M -3.59M
Operating Cash Flow
-29,792B -17.93M -16.29M -19.49M
Capital Expenditures
n/a -14K n/a n/a
Cash Acquisitions
-3,648B n/a n/a n/a
Purchase of Investments
19,977B n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-19,977B n/a n/a n/a
Investing Cash Flow
-3,648B -14K n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
19,977B n/a n/a 55.56M
Financial Cash Flow
33,976B -17,936B n/a 55.56M
Net Cash Flow
517B -17.94M -16.31M 36.05M
Free Cash Flow
-29,792B -17.95M -16.29M -19.49M